SunTrust Upgrades Abaxis (ABAX) to Buy
More News related to ABAX
- Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2010
- Abaxis to Report Second Quarter Fiscal 2010 Financial Results Tuesday, October 27, 2009
- Trading Radar for 10/27: Visa (V), Baidu.com (BIDU), WYNN Resorts (WYNN), RF Micro (RFMD), BP (BP) Report
- Abaxis to Report Second Quarter Fiscal 2010 Financial Results Tuesday, October 27, 2009
- SunTrust Downgrades Abaxis (ABAX) to Neutral
SunTrust upgrades Abaxis (Nasdaq: ABAX) from Neutral to Buy. Price target $21.
Abaxis, Inc. (Abaxis) develops, manufactures, markets and sells portable blood analysis systems for use in any human or veterinary patient-care setting to provide clinicians with rapid blood constituent measurements.
Related Categories
UpgradesStocks Mentioned
-0.40Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
